• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对慢性阻塞性肺疾病的社区肺康复项目的经济学评估

Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease.

作者信息

Golmohammadi Kamran, Jacobs Philip, Sin Don D

机构信息

Institute of Health Economics, Edmonton, Alberta, Canada.

出版信息

Lung. 2004;182(3):187-96. doi: 10.1007/s00408-004-3110-2.

DOI:10.1007/s00408-004-3110-2
PMID:15526757
Abstract

Pulmonary rehabilitation has been demonstrated to be efficacious in chronic obstructive pulmonary disease (COPD), however, its cost-effectiveness is largely unknown. The present study determined the cost-effectiveness of a community-based pulmonary rehabilitation program for COPD patients with mild, moderate, and severe disease. We compared the direct costs (in Canadian dollars) and disease-specific quality of life (measured by the St. George's Respiratory Questionnaire, SGRQ) of patients with COPD (N = 210) who enrolled in the rehabilitation program in Edmonton, Canada one year before and after completion of the program. To determine temporal trends in health service utilization between 2000 and 2002 we used similar data from 592 COPD patients from the same region who did not participate in the rehabilitation program. We found that the health status of patients enrolled in the program improved significantly following pulmonary rehabilitation, irrespective of the severity of disease (total SGRQ score improved by 4.85%, p = 0.001). The total direct cost per 100 person-years of follow-up before the program was $122,071 (SE = 29,566); after the program it was $87,704 (SE = 26,146). The average reduction of total costs before and after the program was $34,367 per 100 person-years or approximately $344 per person per year (p = 0.02). Over one-year, pulmonary rehabilitation was associated with decreased health service utilization, reduced direct costs and improved health status of COPD patients. This suggests that pulmonary rehabilitation is cost-effective for patients with relatively high utilization of emergency and hospital-based services.

摘要

肺康复已被证明对慢性阻塞性肺疾病(COPD)有效,然而,其成本效益在很大程度上尚不清楚。本研究确定了一项针对轻度、中度和重度COPD患者的社区肺康复计划的成本效益。我们比较了加拿大埃德蒙顿参加康复计划的COPD患者(N = 210)在计划完成前一年和完成后一年的直接成本(以加元计)以及疾病特异性生活质量(通过圣乔治呼吸问卷,SGRQ测量)。为了确定2000年至2002年期间卫生服务利用的时间趋势,我们使用了来自同一地区未参加康复计划的592名COPD患者的类似数据。我们发现,参加该计划的患者在肺康复后健康状况显著改善,无论疾病严重程度如何(SGRQ总分提高了4.85%,p = 0.001)。该计划前每100人年随访的总直接成本为122,071加元(标准误 = 29,566);计划后为87,704加元(标准误 = 26,146)。计划前后总成本的平均降低为每100人年34,367加元,或每人每年约344加元(p = 0.02)。在一年的时间里,肺康复与COPD患者卫生服务利用的减少、直接成本的降低以及健康状况的改善相关。这表明,对于急诊和基于医院服务利用率相对较高的患者,肺康复具有成本效益。

相似文献

1
Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease.一项针对慢性阻塞性肺疾病的社区肺康复项目的经济学评估
Lung. 2004;182(3):187-96. doi: 10.1007/s00408-004-3110-2.
2
Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients.社区慢性阻塞性肺疾病的管理。一项针对居家老年患者的家庭肺康复随机对照试验。
J Cardiopulm Rehabil. 2005 Nov-Dec;25(6):378-85. doi: 10.1097/00008483-200511000-00012.
3
Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease.线性模拟量表问卷在测量老年慢性阻塞性肺疾病患者健康相关生活质量方面的实用性。
J Am Geriatr Soc. 2003 Aug;51(8):1131-5. doi: 10.1046/j.1532-5415.2003.51363.x.
4
Pulmonary rehabilitation: analysis of a clinical service.肺康复:一项临床服务分析
Physiother Res Int. 2004;9(3):111-20. doi: 10.1002/pri.311.
5
Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).慢性阻塞性肺疾病(COPD)患者接受噻托溴铵加常规护理与仅接受常规护理治疗1年后的医疗费用。
Pharmacoeconomics. 2004;22(11):741-9. doi: 10.2165/00019053-200422110-00004.
6
Effectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.家庭式肺康复对慢性阻塞性肺疾病患者的有效性:一项随机对照试验的荟萃分析
Rehabil Nurs. 2014 Jan-Feb;39(1):36-59. doi: 10.1002/rnj.112. Epub 2013 Jun 18.
7
A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods.一项关于慢性阻塞性肺疾病居家肺康复的加拿大多中心随机临床试验:原理与方法
Can Respir J. 2005 May-Jun;12(4):193-8. doi: 10.1155/2005/606378.
8
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.罗氟司特治疗重度慢性阻塞性肺疾病患者的1年前瞻性成本效益分析。
Pharmacoeconomics. 2007;25(8):695-711. doi: 10.2165/00019053-200725080-00007.
9
Reduction in hospitalisation following pulmonary rehabilitation in patients with COPD.慢性阻塞性肺疾病患者肺康复后住院率的降低。
Aust Health Rev. 2008 Aug;32(3):415-22. doi: 10.1071/ah080415.
10
Impact of an integrated disease management program in reducing exacerbations in patients with severe asthma and COPD.综合疾病管理项目对减少重度哮喘和慢性阻塞性肺疾病患者病情加重的影响。
Respir Med. 2014 Dec;108(12):1794-800. doi: 10.1016/j.rmed.2014.09.010. Epub 2014 Sep 28.

引用本文的文献

1
Cost effectiveness of a novel swallowing and respiratory sensation assessment and a modelled intervention to reduce acute exacerbations of COPD.一种新型吞咽与呼吸感觉评估及一种用于减少慢性阻塞性肺疾病急性加重的模拟干预措施的成本效益。
BMC Pulm Med. 2025 Apr 9;25(1):165. doi: 10.1186/s12890-025-03615-y.
2
Review of the Evidence for Pulmonary Rehabilitation in COPD: Clinical Benefits and Cost-Effectiveness.COPD 肺康复的证据回顾:临床获益和成本效益。
Respir Care. 2024 May 28;69(6):686-696. doi: 10.4187/respcare.11541.
3
Effectiveness of Water-Based Exercise in Patients with Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis.

本文引用的文献

1
Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials.慢性阻塞性肺疾病患者的康复治疗:随机对照试验的荟萃分析
J Gen Intern Med. 2003 Mar;18(3):213-21. doi: 10.1046/j.1525-1497.2003.20221.x.
2
Interpreting thresholds for a clinically significant change in health status in asthma and COPD.解读哮喘和慢性阻塞性肺疾病(COPD)健康状况临床显著变化的阈值
Eur Respir J. 2002 Mar;19(3):398-404. doi: 10.1183/09031936.02.00063702.
3
Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme.
基于水的运动对慢性阻塞性肺疾病患者的有效性:系统评价和荟萃分析。
Sensors (Basel). 2023 Oct 18;23(20):8557. doi: 10.3390/s23208557.
4
Technological advances and digital solutions to improve quality of life in older adults with chronic obstructive pulmonary disease: a systematic review.技术进步和数字解决方案改善慢性阻塞性肺疾病老年患者的生活质量:系统评价。
Aging Clin Exp Res. 2023 May;35(5):953-968. doi: 10.1007/s40520-023-02381-3. Epub 2023 Mar 23.
5
Osteosarcopenia in Patients with Chronic Obstructive Pulmonary Diseases: Which Pathophysiologic Implications for Rehabilitation?慢性阻塞性肺疾病患者的肌骨减少症:对康复有哪些病理生理影响?
Int J Environ Res Public Health. 2022 Nov 2;19(21):14314. doi: 10.3390/ijerph192114314.
6
Pharmacological, Nutritional, and Rehabilitative Interventions to Improve the Complex Management of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review.改善慢性阻塞性肺疾病患者骨质疏松复杂管理的药理学、营养和康复干预:一项叙述性综述
J Pers Med. 2022 Oct 1;12(10):1626. doi: 10.3390/jpm12101626.
7
Embedding Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease in the Home and Community Setting: A Rapid Review.将慢性阻塞性肺疾病的肺康复融入家庭和社区环境:快速综述
Front Rehabil Sci. 2022 Mar 30;3:780736. doi: 10.3389/fresc.2022.780736. eCollection 2022.
8
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting.基层医疗环境中针对高危、易加重的慢性阻塞性肺疾病患者的综合疾病管理的成本效益
Cost Eff Resour Alloc. 2022 Aug 12;20(1):39. doi: 10.1186/s12962-022-00377-w.
9
Closing the Gap between Inpatient and Outpatient Settings: Integrating Pulmonary Rehabilitation and Technological Advances in the Comprehensive Management of Frail Patients.缩小住院和门诊环境之间的差距:将肺康复与技术进步相结合,综合管理虚弱患者。
Int J Environ Res Public Health. 2022 Jul 27;19(15):9150. doi: 10.3390/ijerph19159150.
10
Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease.美国慢性阻塞性肺疾病成人患者肺康复的成本效益分析。
JAMA Netw Open. 2022 Jun 1;5(6):e2218189. doi: 10.1001/jamanetworkopen.2022.18189.
门诊多学科肺康复计划的成本效益
Thorax. 2001 Oct;56(10):779-84. doi: 10.1136/thorax.56.10.779.
4
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.慢性阻塞性肺疾病诊断、管理和预防全球策略。美国国立心肺血液研究所/世界卫生组织慢性阻塞性肺疾病全球倡议(GOLD)研讨会总结。
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039.
5
Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD.使用通用工具(简短健康调查问卷-36)测量的生活质量在慢性阻塞性肺疾病(COPD)患者进行肺康复后有所改善。
Chest. 2001 Jan;119(1):77-84. doi: 10.1378/chest.119.1.77.
6
Quality of life after pulmonary rehabilitation: assessing change using quantitative and qualitative methods.
Phys Ther. 2000 Oct;80(10):986-95.
7
Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures.肺康复对慢性阻塞性肺疾病患者生活质量的影响:使用SF-36总结评分作为结局指标。
J Cardiopulm Rehabil. 2000 Jul-Aug;20(4):231-4. doi: 10.1097/00008483-200007000-00003.
8
Exercise rehabilitation and chronic obstructive pulmonary disease stage.运动康复与慢性阻塞性肺疾病分期
Am J Respir Crit Care Med. 1999 Oct;160(4):1248-53. doi: 10.1164/ajrccm.160.4.9901014.
9
Pulmonary rehabilitation-1999. American Thoracic Society.肺康复——1999年。美国胸科学会。
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1666-82. doi: 10.1164/ajrccm.159.5.ats2-99.
10
Pulmonary rehabilitation programs in Canada: national survey.加拿大的肺康复项目:全国性调查。
Can Respir J. 1999 Jan-Feb;6(1):55-63.